Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MoonLake Immunotherapeutics | 8,494,151 | reported | 05 Oct 2023 | tx 1+58,839 |
| Avidity Biosciences, Inc. | 0 | reported | 16 Jun 2020 | tx 3+4,729,090 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Oct 2023 | PURCHASE | MoonLake Immunotherapeutics | 58,839 | 59.90 USD | first after silence |
| 16 Jun 2020 | PURCHASE | Avidity Biosciences, Inc. | 300,000 | 18.00 USD | |
| 16 Jun 2020 | CONVERSION | Avidity Biosciences, Inc. | 2,214,545 | — | |
| 16 Jun 2020 | CONVERSION | Avidity Biosciences, Inc. | 2,214,545 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 05 Oct 2023.